naphthalene has been researched along with Pulmonary Hypertension in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "These findings suggested that ACE2 activation by resorcinolnaphthalein improved endothelial function and suppressed neointimal formation in the prevention of severe PAH by the mechanism of mediating the levels of the components of the renin-angiotensin system." | 3.79 | ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats. ( Li, G; Li, X; Li, Z; Liu, A; Liu, Y; Su, J; Sun, L; Xu, Y; Zhu, Y, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, G | 1 |
| Liu, Y | 1 |
| Zhu, Y | 1 |
| Liu, A | 1 |
| Xu, Y | 1 |
| Li, X | 1 |
| Li, Z | 1 |
| Su, J | 1 |
| Sun, L | 1 |
1 other study available for naphthalene and Pulmonary Hypertension
| Article | Year |
|---|---|
ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Arterial Pressure; Cytoprot | 2013 |